Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.jtcvs.2019.07.066 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Making a 'spleen getaway': no infectious association or chasing the diagnosis?
Trauma Surg Acute Care Open
August 2025
Department of General Surgery, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
Management of human babesiosis - approaches and perspectives.
Expert Rev Anti Infect Ther
September 2025
Department of Epidemiology of Microbial Diseases, Yale School of Public Health and Department of Medicine, Section of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA.
Introduction: Human babesiosis is an emerging tick-borne disease caused by intraerythrocytic protozoa. Most cases are due to which is endemic in the northeastern and upper Midwestern United States. Other spp.
View Article and Find Full Text PDFSplenectomy and complications: A complex different disease background, yet a common denominator exists.
Br J Haematol
July 2025
Thalassaemia and Sickle Cell Disease Unit, Department of Haematology, General Hospital of Larissa, Larissa, Greece.
Splenectomy is a major element in the treatment of hemoglobinopathies, such as transfusion dependent thalassaemia (TDT), non-transfusion dependent thalassaemia (NTDT), sickle cell anaemia (SCA), other red cell disorders like spherocytosis or other haematological diseases of autoimmune origin. A recent, long-year study describes a large series of splenectomized patients in Italy. The authors of this systematic work found that the probability of a post-splenectomy complication depends on the underlying disease and not on the age of the patient at splenectomy.
View Article and Find Full Text PDFThe usefulness of indium-111 platelet scintigraphy beyond predicting efficacy of splenectomy.
Br J Haematol
January 2025
Coagulopathies and Disorders of Haemostasis Group, IdiPAZ-Hospital Universitario La Paz, Madrid, Spain.
There are no clear indicators to predict the outcome of patients with immune thrombocytopenia or the response to drugs. The work of Durand et al. shows that Indium-111 platelet scintigraphy is useful in identifying those patients who will benefit from splenectomy and lays the groundwork for studies demonstrating the increased corticosteroid dependency and rituximab refractoriness of the hepatic platelet sequestration group.
View Article and Find Full Text PDFACVIM consensus statement on the treatment of immune thrombocytopenia in dogs and cats.
J Vet Intern Med
July 2024
Langford Vets, University of Bristol, Langford, Somerset, United Kingdom.
Article Synopsis
- Management of immune thrombocytopenia (ITP) in dogs and cats lacks established evidence-based guidelines, leaving treatment decisions largely to clinician discretion.
- The first-line treatment involves immunosuppressive glucocorticoids, with additional therapies such as azathioprine and vincristine used in more severe cases; however, optimal regimens are still unclear.
- A consensus process involving a structured literature review and expert opinions led to the creation of guidelines highlighting the need for further research in ITP treatment options.